baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

BVT Call 140 6MK 21.06.2024/ DE000VD0NMX9 /

09/05/2024 20:01:57	Chg.0.000	Bid21:55:49	Ask21:50:08	Underlying	Strike price	Expiration date	Option type
0.024EUR	0.00%	- Bid Size: -	- Ask Size: -	MERCK CO. D...	140.00 -	21/06/2024	Call

GlobeNewswire 09/05 PDS Biotech VERSATILE-002 Phase 2 Clinical Trial Meets Primary Study Endpoints in First Line Recurre...

GlobeNewswire 09/05 PMV Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Highlights

GlobeNewswire 09/05 Mersana Therapeutics Provides Business Update and Announces First Quarter 2024 Financial Results

GlobeNewswire 07/05 CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...

GlobeNewswire 06/05 Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...

GlobeNewswire 02/05 Cerevance Achieves First Milestone in Research Collaboration with Merck

TeleTrader 25/04 Merck's Q1 sales rise by 9% to $15.8 billion

GlobeNewswire 02/04 Vaccinex Reports 2023 Financial Results and Provides Corporate Update

GlobeNewswire 06/03 IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Can...

GlobeNewswire 04/03 C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...

TeleTrader 02/02 Merck Group to expand investment in South Korea

TeleTrader 01/02 Merck's Q4 sales up 6% to $14.6B

TeleTrader 27/01 J&J, Merck CEOs to testify before Senate on drug prices

GlobeNewswire 23/01 Unnatural Products, Inc. Enters Research Collaboration with Merck

GlobeNewswire 21/12/2023 Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...

GlobeNewswire 19/12/2023 Unnatural Products, Inc. Announces $32 Million in Series A Funding Led by Merck Global Health Innova...

GlobeNewswire 14/12/2023 ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...

GlobeNewswire 12/12/2023 C4 Therapeutics Announces License and Research Collaboration with Merck to Discover and Develop Degr...

GlobeNewswire 05/12/2023 HiberCell, Inc. Announces Clinical Collaboration with Merck to Evaluate HC-7366, an Activator of ISR...

GlobeNewswire 04/12/2023 Nasdaq Grants Vaccinex Extension Until March 4, 2024 to Regain Compliance with Listing Rule

GlobeNewswire 13/11/2023 Vaccinex Reports Third Quarter 2023 Financial Results and Provides Corporate Update

TeleTrader 26/10/2023 Merck's Q3 sales up 7% to $16B

TeleTrader 20/10/2023 Daiichi Sankyo, Merck announce collaboration on cancer drugs

GlobeNewswire 17/10/2023 ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA

GlobeNewswire 28/09/2023 Merck KGaA, Darmstadt, Germany and Quris-AI Expand Collaboration

BVT Call 140 6MK 21.06.2024/ DE000VD0NMX9 /

If you wish to receive reply to your feedback, please provide your email address.